Seroprevalence of hepatitis virus B seropositive in the patients with cholangiocarcinoma: a summary.
Article
in English
| IMSEAR
| ID: sea-37917
ABSTRACT
The exact etiology of cholangiocarcinoma remains undetermined. One of the related risk factors for its development might be chronic viral hepatitis infection. Concerning hepatitis B infection, a correlation with cholangiocarcinoma has been documented. Here, we summarize knowledge on the prevalence of hepatitis B seropositivity among patients with cholangiocarcinomas. According to the literature review, five reports were recruited for further metanalysis, covering 565 cases. The overall prevalence of seropositive cancer was 14.5% (83/565). Further analysis revealed no correlation between prevalence rate and nationality of the studied population (P > 0.05). Therefore, hepatitis B infection might be a contributing factor for cholangiocarcinoma development.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Thailand
/
Bile Duct Neoplasms
/
Female
/
Humans
/
Male
/
Chi-Square Distribution
/
Seroepidemiologic Studies
/
Hepatitis B virus
/
Prevalence
/
Risk Factors
Type of study:
Etiology study
/
Prevalence study
/
Risk factors
Country/Region as subject:
Asia
Language:
English
Year:
2005
Type:
Article
Similar
MEDLINE
...
LILACS
LIS